WHO ICTRP trial
Effect of melatonin on diabetes
IRCT2016010520219N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016010520219N2 |
|---|---|
| Public title | Effect of melatonin on diabetes |
| Scientific title | Effect of melatonin on serum glucose level in patiets with type 2 diabetes |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | type 2 diabetes. Non-insulin-dependent diabetes mellitus;Non-insulin-dependent diabetes mellitus |
| Interventions | Intervention 1: intervention: melatonin 6 mg. Intervention 2: control : placebo.;Treatment - Drugs;Treatment - Drugs;intervention: melatonin 6 mg;control : placebo |
| Registration date | Mar 13, 2016 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: